Search research articles
Contact Us
Filters
Showing results (311-320 of 323) with videos related to
Page
of 33
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitors
Sanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Virology
|
February 1, 2005
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy
Neil Gupta, James Arthos, Prateeti Khazanie, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors
Kenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Carl R Illig, Jinsheng Chen, Mark J Wall, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)
Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors
Carl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Monthly Notices of the Royal Astronomical Society
|
October 30, 2023
FLAMINGO: calibrating large cosmological hydrodynamical simulations with machine learning
Roi Kugel, Joop Schaye, Matthieu Schaller, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors
Mark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Carl L Manthey, Dana L Johnson, Carl R Illig, et al.
Science (New York, N.Y.)
|
March 19, 2016
The geology of Pluto and Charon through the eyes of New Horizons
Jeffrey M Moore, William B McKinnon, John R Spencer, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 323) with videos related to
Sort By:
Page
of 33
Bioorganic & Medicinal Chemistry Letters
|
May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitors
Sanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Virology
|
February 1, 2005
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy
Neil Gupta, James Arthos, Prateeti Khazanie, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors
Kenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
Carl R Illig, Jinsheng Chen, Mark J Wall, et al.
Journal of Medicinal Chemistry
|
November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)
Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors
Carl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Monthly Notices of the Royal Astronomical Society
|
October 30, 2023
FLAMINGO: calibrating large cosmological hydrodynamical simulations with machine learning
Roi Kugel, Joop Schaye, Matthieu Schaller, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors
Mark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Carl L Manthey, Dana L Johnson, Carl R Illig, et al.
Science (New York, N.Y.)
|
March 19, 2016
The geology of Pluto and Charon through the eyes of New Horizons
Jeffrey M Moore, William B McKinnon, John R Spencer, et al.
Page
of 33